Sanofi Pasteur Introduces 4-Strain Influenza Vaccine (Fluzone) in Canada

New standard of care for the prevention of influenza A 4-strain influenza vaccine for individuals six months of age and older Helps protect children and adults against an additional influenza B strain October 1, 2014 Sanofi Pasteur, the vaccines division of Sanofi, is pleased to announce the launch of its 4-strain influenza vaccine (Fluzone® Quadrivalent) in Canada. This new vaccine was introduced …

Sanofi Pasteur Announces Publication of Positive Data for Fluzone High-Dose Vaccine in the New England Journal of Medicine

Study Demonstrates Fluzone High-Dose Vaccine 24.2 Percent More Effective Than Standard-Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older August 13, 2014 Sanofi Pasteur, the vaccines division of Sanofi, today announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone® High-Dose (Influenza Vaccine) was …

Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States

Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season July 22, 2014 Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone® (Influenza Vaccine) for the 2014-2015 influenza (“the flu”) season have been released by the …

Top 10 Vaccines in 2013

  #10 – Pneumovax Pneumococcal infection 2013 – $653 million 2012 – $580 million Marketed by Merck and Sanofi Pasteur MSD #9 – RotaTeq Rotaviral gastroenteritis 2013 – $691 million 2012 – $648 million Marketed by Merck and Sanofi Pasteur MSD #8 – Zostavax Herpes Zoster (Shingles) 2013 – $826 million 2012 – $ N/A Marketed by Merck and Sanofi Pasteur MSD #7 – Hepatitis vaccine franchise Hepatitis A, Hepatitis B 2013 – $984 million 2012 …

Sanofi nabs quadrivalent flu vaccine FDA approval for under 2s

Sanofi Pasteur has announced that the US Food and Drug Administration (FDA) has approved its four-strain influenza vaccine, Fluzone Quadrivalent. Whilst trivalent vaccines used in previous influenza seasons contained two A strains and one B strains, a quadrivalent vaccine such as Fluzone will also offer protection against a second type B flu strain. The 2013 season will be the first …

Efficacy study of Fluzone® High-Dose vaccine compared with Fluzone® in Elderly Adults

Efficacy study of Fluzone® High-Dose vaccine compared with Fluzone® in Elderly Adults · Randomized, modified double-blind, active controlled, multi-center trial Primary Objective: · Compare clinical efficacy of Fluzone® HD to Fluzone® in elderly adults, with respect to laboratory confirmed influenza, caused by any viral types/subtypes, associated with a protocol-defined Influenza Like Illness (ILI) Primary Endpoint · Occurrences of culture- or …